Bluesight announces the acquisition of Sectyr, a compliance and audit management platform, expanding Bluesight’s portfolio to include 340B audit and compliance tools. Sectyr offers solutions for streamlining regulatory compliance and auditing, specifically within the 340B drug pricing program. The acquisition is intended to help Bluesight enhance medication safety, compliance, and operational efficiency in health systems. With this technology integration, Bluesight customers now have access to a suite of tools to manage their 340B program, helping to improve audit readiness and compliance oversight.